Morgan Stanley Sema4 Holdings Corp. Transaction History

Morgan Stanley

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.24 - $0.52 $3,716 - $8,053	15,487 Added 6.94%	238,662 $81,000
Q4 2022 Feb 14, 2023	BUY	$0.22 - $1.04 $30,529 - $144,321	138,771 Added 164.41%	223,175 $58,000
Q3 2022 Nov 14, 2022	SELL	$0.25 - $2.4 $60,729 - $583,005	-242,919 Reduced 74.21%	84,404 $74,000
Q2 2022 Oct 27, 2022	BUY	$1.22 - $3.05 $211,651 - $529,129	173,485 Added 112.77%	327,323 $413,000
Q2 2022 Aug 15, 2022	BUY	$1.22 - $3.05 $211,651 - $529,129	173,485 Added 112.77%	327,323 $413,000
Q1 2022 Oct 27, 2022	SELL	$2.64 - $4.67 $458,000 - $810,174	-173,485 Reduced 53.0%	153,838 $472,000
Q1 2022 May 13, 2022	SELL	$2.64 - $4.67 $10.2 Million - $18.1 Million	-3,873,941 Reduced 96.18%	153,838 $472,000
Q4 2021 Feb 14, 2022	BUY	$4.4 - $8.8 $1.67 Million - $3.34 Million	379,795 Added 10.41%	4,027,779 $18 Million
Q3 2021 Nov 15, 2021	BUY	$7.44 - $13.99 $27.1 Million - $51 Million	3,647,984 New	3,647,984 $27.7 Million

166K

Ticker SMFR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 380,641,984
Market Cap $129M
Description
Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commerc...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.